We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Animal Cell Therapies Announces Cell Inventory Value at $6 Million
News

Animal Cell Therapies Announces Cell Inventory Value at $6 Million

Animal Cell Therapies Announces Cell Inventory Value at $6 Million
News

Animal Cell Therapies Announces Cell Inventory Value at $6 Million

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Animal Cell Therapies Announces Cell Inventory Value at $6 Million"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

When Animal Cell Therapies was created, the company partnered with a select group of researchers, scientists and collaborators from the U.S. and abroad to create an in-house program to grow and expand well-characterized animal stem cells in a scientific setting. The company's founder, Dr. Kathryn Petrucci, recognized that in order to provide pure, potent, reliable, pathogen-free animal stem cells, ACT must optimize stem cell storage while improving stem cell transportation procedures and delivery techniques.

"This valuation essentially validates that the foundation we've set for this company -- in the creation and maintaining of this stem cell inventory -- is sound and will support the next steps in our strategy," said Adam Irving, chief executive officer of Animal Cell Therapies. "Our capabilities are far reaching with broad applications."

In maintaining its stem cell inventory, Animal Cell Therapies conducts specific cell assays, characterization processes and procedures to assess potential toxicity and consistently assure safety, purity, potency and a stable finished stem cell product or stem cell derivative. In addition, Animal Cell Therapies monitors processes with standardized, rigorous quality control specifications and testing parameters.

Advertisement